Concepedia

Megumi Yoshikawa

MY

Statistics

Publications

10

Citations

707

H-Index

10

Active since

1990

Affiliations

Meiji Pharmaceutical University(Current)

Tokyo Institute of Technology

Nagasaki University

Hokkaido University

Yakult Central Institute

Megumi Yoshikawa is an author at Meiji Pharmaceutical University specializing in medicine, pharmacology, and cancer pharmacology.

Publications per year

1990–2015

10

Publications

10

Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells

Katsumi Nakatomi, Megumi Yoshikawa, Mikio Oka et al. · Biochemical and Biophysical Research Communications · 2001 · 188 citations

, , +12

Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance

Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text

, , +15

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

Ken Shiozawa, Mikio Oka, Hiroshi Soda et al. · International Journal of Cancer · 2003 · 121 citations

, , +16

Transport of SN-38 by the wild type of human ABC transporter ABCG2 and its inhibition by quercetin, a natural flavonoid.

Megumi Yoshikawa, Yoji Ikegami, Kazumi Sano et al. · PubMed · 2004 · 67 citations

, , +15

Novel camptothecin analogues that circumvent ABCG2‐associated drug resistance in human tumor cells

Megumi Yoshikawa, Yoji Ikegami, Shinya Hayasaka et al. · International Journal of Cancer · 2004 · 63 citations · Full text

, , +14

1–5 of 10